Adherence to K/DOQI Bone Metabolism Guidelines

Journal of Renal Nutrition

Volumn 19, Issue 4, 2009, Pages 334-342

  Smith, David H ^a   Johnson, Eric S ^a   Thorp, Micah L ^b   Yang, Xiuhai ^a  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; BLOOD; BONE; BONE DISEASE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; GLOMERULUS FILTRATION RATE; HUMAN; METABOLISM; PRACTICE GUIDELINE; RETROSPECTIVE STUDY;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DISEASES; CALCIUM; COHORT STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; PARATHYROID HORMONE; PHOSPHORUS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES;

EID: 67149133363     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2009.01.013     Document Type: Article

References (13)

1. Eastwood J.B., Stamp T.C., Harris E., et al. Vitamin-D deficiency in the osteomalacia of chronic renal failure. Lancet 2 (1976) 1209-1211
2. Ishimura E., Nishizawa Y., Inaba M., et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55 (1999) 1019-1027
3. London G.M., Guerin A.P., Marchais S.J., et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18 (2003) 1731-1740
4. Tomiyama C., Higa A., Dalboni M.A., et al. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant 21 (2006) 2464-2471
5. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 Suppl (2003) S1-S201
6. Manjunath M., Sarnak M., and Levey A. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens 10 (2001) 785-792
7. DeFrances C.J., and Podgornik M.N. 2004 National Hospital Discharge Survey. Adv Data 371 (2006) 1-19
8. Avorn J., Bohn R.L., Levy E., et al. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med 162 (2002) 2002-2006
9. Winkelmayer W.C., Levin R., and Avorn J. The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Kidney Int 63 (2003) 1836-1842
10. Keith D.S., Nichols G.A., Gullion C.M., et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
11. United States Renal Data System. USRDS 2006 annual data report: atlas of end-stage renal disease in the United States (2006), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
12. Chernew M. HMO use of diagnostic tests: a review of the evidence. Med Care Res Rev 52 (1995) 196-222
13. Wang Y.R., and Pauly M.V. Difference in the use of preventive services between fee-for-service plans and HMOs: is more better?. Am J Manag Care 9 (2003) 293-301